Who is Claritas pharmaceuticals?

Claritas Pharmaceuticals, Inc. engages in the development of next generation cannabinoid therapeutics. It also offers development programs for bone fracture healing, osteogenesis imperfecta, osteoporosis, and osteoporosis in Prader-Willi syndrome. The company was founded by Seth Yakatan on October 15, 2004 and is headquartered in San Rafael, CA.

When did Claritas Pharmaceuticals stock split?

Claritas Pharmaceuticals, Inc. (OTCMKTS:KALTF) posted its quarterly earnings data on Friday, November, 29th. The company reported ($0.40) earnings per share (EPS) for the quarter. When did Claritas Pharmaceuticals' stock split? Claritas Pharmaceuticals's stock reverse split on Friday, July 23rd 2021.

Does Claritas pharmaceuticals (clazf) have a liquid biopsy test?

It is developing liquid biopsy tests for molecular residual disease, colorectal cancer screening, and multicancer screening, too. Find the latest Claritas Pharmaceuticals, Inc. (CLAZF) stock quote, history, news and other vital information to help you with your stock trading and investing.

What is the Claritas Investment Certificate?

The Claritas Investment Certificate is a program that focuses on investment industry basics and the roles and responsibilities of financial services professionals. The program is an online, self-study course, with seven course modules covering various topics, such as industry controls and ethics and regulations.